Cover Page
Cover Page - shares | 3 Months Ended | |
Mar. 31, 2022 | Apr. 29, 2022 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2022 | |
Document Transition Report | false | |
Entity File Number | 001-37480 | |
Entity Registrant Name | UNIQUE FABRICATING, INC. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 46-1846791 | |
Entity Address, Address Line One | 800 Standard Parkway | |
Entity Address, City or Town | Auburn Hills | |
Entity Address, State or Province | MI | |
Entity Address, Postal Zip Code | 48326 | |
City Area Code | 248 | |
Local Phone Number | 853-2333 | |
Title of 12(b) Security | Common Stock, par value $.001 per share | |
Trading Symbol | UFAB | |
Security Exchange Name | NYSEAMER | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 11,733,147 | |
Entity Central Index Key | 0001617669 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2022 | |
Document Fiscal Period Focus | Q1 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Current assets | ||
Cash and cash equivalents | $ 752 | $ 742 |
Accounts receivable, net of reserves of approximately $1.1 million and $1.3 million at March 31, 2022 and December 31, 2021, respectively | 26,566 | 23,469 |
Inventory, net | 13,477 | 13,770 |
Prepaid expenses and other current assets: | ||
Prepaid expenses and other | 3,099 | 3,270 |
Refundable taxes | 4,342 | 3,738 |
Total current assets | 48,236 | 44,989 |
Property, plant, and equipment, net | 21,981 | 22,567 |
Goodwill | 16,996 | 16,996 |
Intangible assets | 4,700 | 5,161 |
Other assets | ||
Operating leases | 9,757 | 9,776 |
Investments, at cost | 1,054 | 1,054 |
Deposits and other assets | 775 | 755 |
Deferred tax asset | 2,379 | 2,379 |
Total assets | 105,878 | 103,677 |
Current liabilities: | ||
Accounts payable | 14,117 | 10,056 |
Current maturities of long-term debt | 27,713 | 28,884 |
Income taxes payable | 311 | 303 |
Revolver, current maturities | 19,336 | 19,541 |
Accrued compensation | 1,709 | 1,149 |
Other accrued liabilities | 3,237 | 3,478 |
Total current liabilities | 66,423 | 63,411 |
Long-term debt, net of current maturities | 0 | 0 |
Other long-term liabilities: | ||
Other liabilities | 8,856 | 9,139 |
Total liabilities | 75,279 | 72,550 |
Stockholders’ equity: | ||
Common stock, $0.001 par value: 15,000,000 shares authorized and 11,733,147 and 11,733,147 issued and outstanding at March 31, 2022 and December 31, 2021, respectively | 12 | 12 |
Additional paid-in-capital | 50,390 | 50,349 |
Accumulated deficit | (19,803) | (19,234) |
Total stockholders’ equity | 30,599 | 31,127 |
Total liabilities and stockholders’ equity | $ 105,878 | $ 103,677 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions | Mar. 31, 2022 | Dec. 31, 2021 |
Statement of Financial Position [Abstract] | ||
Allowance for doubtful accounts receivable | $ 1.1 | $ 1.3 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 15,000,000 | 15,000,000 |
Common stock, shares issued (in shares) | 11,733,147 | 11,733,147 |
Common stock, shares outstanding (in shares) | 11,733,147 | 11,733,147 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Income Statement [Abstract] | ||
Net sales | $ 35,312 | $ 34,798 |
Cost of sales | 30,534 | 28,936 |
Gross profit | 4,778 | 5,862 |
Selling, general, and administrative expenses | 4,972 | 5,814 |
Operating income (loss) | (194) | 48 |
Other income (expense): | ||
Other, net | (59) | 18 |
Interest expense | (481) | (693) |
Other expense, net | (540) | (675) |
Loss before income taxes | (734) | (627) |
Income tax expense (benefit) | (165) | 442 |
Net loss | $ (569) | $ (1,069) |
Net loss per share: | ||
Basic (in dollars per share) | $ (0.05) | $ (0.11) |
Diluted (in dollars per share) | $ (0.05) | $ (0.11) |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands | Total | Common Stock | Additional Paid-In Capital | Accumulated Deficit |
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2020 | 9,779,147 | |||
Stockholders' equity, beginning balance at Dec. 31, 2020 | $ 33,865 | $ 10 | $ 46,126 | $ (12,271) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||
Net loss | (1,069) | (1,069) | ||
Stock option expense | 27 | 27 | ||
Stockholders' equity, ending balance (in shares) at Mar. 31, 2021 | 9,779,147 | |||
Stockholders' equity, ending balance at Mar. 31, 2021 | 32,823 | $ 10 | 46,153 | (13,340) |
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2021 | 11,733,147 | |||
Stockholders' equity, beginning balance at Dec. 31, 2021 | 31,127 | $ 12 | 50,349 | (19,234) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||
Net loss | (569) | (569) | ||
Stock option expense | 41 | 41 | ||
Stockholders' equity, ending balance (in shares) at Mar. 31, 2022 | 11,733,147 | |||
Stockholders' equity, ending balance at Mar. 31, 2022 | $ 30,599 | $ 12 | $ 50,390 | $ (19,803) |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Cash Flows from Operating Activities: | ||
Net loss | $ (569) | $ (1,069) |
Adjustments to reconcile net loss to net cash provided by operating activities: | ||
Depreciation and amortization | 1,276 | 1,644 |
Amortization of debt issuance costs | 56 | 45 |
Loss on sale of assets | 0 | 14 |
Bad debt adjustment | (72) | (118) |
Loss (gain) on derivative instrument | (380) | (185) |
Stock option expense | 41 | 27 |
Accrued in-kind interest on long term debt | 39 | 0 |
Changes in operating assets and liabilities that provided (used) cash: | ||
Accounts receivable | (3,025) | (3,142) |
Inventory | 293 | (1,611) |
Prepaid expenses and other assets | (452) | 1,317 |
Accounts payable | 4,107 | 3,485 |
Other assets and liabilities, net | 444 | (317) |
Net cash provided by operating activities | 1,758 | 90 |
Cash Flows from Investing Activities: | ||
Capital expenditures | (229) | (1,530) |
Proceeds from sale of property, plant, and equipment | 0 | 65 |
Net cash used for investing activities | (229) | (1,465) |
Cash Flows from Financing Activities: | ||
Net change in bank overdraft | (46) | (922) |
Payments on term loans and capital expenditure line | (1,228) | (1,007) |
Payments on revolving credit facilities | (13,824) | (6,280) |
Proceeds from revolving credit facilities | 13,579 | 11,553 |
Net cash provided by (used for) financing activities | (1,519) | 3,344 |
Cash and Cash Equivalents: | ||
Net increase in cash and cash equivalents | 10 | 1,969 |
Cash and cash equivalents at beginning of period | 742 | 760 |
Cash and cash equivalents at end of period | 752 | 2,729 |
Supplemental Disclosure of Cash Flow Information: | ||
Cash paid for interest | 774 | 815 |
Cash paid for income taxes | $ 112 | $ 226 |
Nature of Business and Basis of
Nature of Business and Basis of Presentation | 3 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Nature of Business and Basis of Presentation | Nature of Business and Basis of Presentation Nature of Business Unique Fabricating, Inc. (the “Company”) engineers and manufactures components for customers in the transportation, appliance, medical, and consumer / off-road markets. The Company’s solutions are comprised of multi-material foam, rubber, and plastic components, and utilized in noise, vibration and harshness (“NVH”) management, acoustical management, water and air sealing, decorative and other functional applications. The Company leverages proprietary manufacturing processes, including die cutting, thermoforming, compression molding, fusion molding, and reaction injection molding to manufacture a wide range of products, including air management products, heating, ventilating, and air conditioning (“HVAC”), seals, fender stuffers, air ducts, acoustical insulation, door water shields, gas tank pads, light gaskets, topper pads, mirror gaskets, glove box liners, personal protection equipment, and packaging. The Company operates as one reportable segment and is headquartered in Auburn Hills, Michigan. Basis of Presentation The Company’s condensed consolidated financial statements have been prepared without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the accompanying condensed consolidated financial statements contain all material adjustments (consisting only of normal recurring adjustments) necessary to present fairly the consolidated financial position of the Company, its results of operations, and its cash flows. The interim results for the periods presented may not be indicative of the Company's actual annual results. The condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Going Concern The Company’s condensed consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of December 31, 2020 and March 31, 2021, the Company was in violation of its financial covenants, as defined in the Company’s Credit Agreement ( Note 6 ). The Company entered into a forbearance agreement, dated April 9, 2021, which allowed the Company to be able to borrow on its revolving line of credit, subject to the terms and conditions to making a revolving credit advance, including availability, and the lenders agreed, subject to the terms of the forbearance agreement, as amended, to forbear from enforcing their rights or seeking to collect payment of the Company’s debt or disposing of the collateral securing the debt. As of September 30, 2021, the Company was also in violation of the required Minimum Consolidated EBITDA covenant (as amended by the Second Amendment to the Forbearance Agreement dated September 21, 2021). On December 9, 2021, the Company entered into the Third Amendment to Forbearance Agreement with respect to the Amended and Restated Credit Agreement, as amended. The Lenders in the Third Amendment to the Forbearance Agreement, among other things, agreed to forbear with respect to the Minimum Consolidated EBITDA covenant violation and to suspend the Minimum Consolidated EBITDA covenant during the remainder of the forbearance period. The Third Amendment included a new covenant that began on December 15, 2021, which is tested weekly on a rolling basis and requires that the Company’s actual cumulative total cash disbursements for the period being tested not exceed total cash disbursements projected by the Company for the same period by more than 15% at any time during the forbearance period. The Third Amendment also reduced the Revolving Credit Aggregate Commitment from $27 million to $25 million. As of December 31, 2021, the Company was in violation of the required Minimum Liquidity covenant, as provided in the Second Amendment to the Forbearance Agreement. As a result, on February 4, 2022, the Company entered into the Fourth Amendment to Forbearance Agreement. The Lenders in the Fourth Amendment to the Forbearance Agreement agreed to waive the Minimum Liquidity covenant violation. On February 25, 2022, the Company entered into the Fifth Amendment to Forbearance Agreement, which extends the Forbearance Period from February 28, 2022, to March 11, 2022. The Company used the short-term extension of its Forbearance Agreement, provided by the Fifth Amendment, to conduct negotiations of a longer extension with the Lenders. On March 11, 2022, the Company entered into the Sixth Amendment to Forbearance Agreement, which extends the Forbearance Period from March 11, 2022, to May 30, 2022. The Company intends to use the latest extension of its Forbearance Agreement, provided by the Sixth Amendment, to pursue a cure or waiver of financial covenant defaults and amended credit agreement The defaults, if not waived by our lenders, allows the lenders to accelerate the maturity of the debt, making it immediately due and payable. Accordingly, all debt subject to the Credit Agreement, totaling $47.0 million, has been classified as current as of March 31, 2022. The Company does not have sufficient cash and cash equivalents on hand or available liquidity to repay such debt or meet its obligations as they become due through twelve months from date of issuance of these condensed consolidated financial statements. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. In response to these conditions, the Company is discussing with its bank lenders entering into an amendment and waiver to cure the covenant defaults. There is not any assurance that the lenders will waive such non compliance or agree to an amendment to the current provisions. Even if the lenders were to agree to waive the failures to comply as of December 31, 2020, March 31, 2021, and September 30, 2021, there cannot be any assurance that, at any future date at which compliance is measured, we will be able to comply with the covenants contained in the forbearance agreement, as amended, given the industry-wide and other challenges that we face, as described elsewhere herein, or that our lenders would waive a default if that were to occur. Furthermore, there can be no assurance that the Company will be able to enter into an amendment or waiver with the lenders or if it enters into an amendment, what the terms, restrictions, and covenants of the amendment will contain. These plans have not been finalized and are not within the Company’s control, and therefore cannot be deemed probable. As a result, the Company has concluded that management’s plans do not alleviate substantial doubt about the Company’s ability to continue as a going concern. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. Concentration Risks The Company is exposed to significant concentration risks as follows: Customer and Credit — During the three months ended March 31, 2022 and March 31, 2021, the Company’s net sales were principally derived from customers engaged in the North American automotive industry. The following table presents the Company's sales directly to General Motors Company (“GM”), Yanfeng Automotive Interiors, Stellantis N.V. (formerly Fiat Chrysler Automobiles), and Ford Motor Company (“Ford”) as a percentage of total net sales: Three Months Ended March 31, 2022 2021 General Motors Company 9 % 7 % Yanfeng Automotive Interiors 10 % 7 % Stellantis N.V. 8 % 6 % Ford Motor Company 5 % 5 % Furthermore, the Company had additional sales to the customers listed in the above table indirectly through other customers. International Operations — The Company manufactures and sells products outside of the United States primarily in Mexico and Canada. Foreign operations are subject to various political, economic and other risks and uncertainties inherent in foreign countries. Among other risks, the Company’s operations may be subject to the risks of: restrictions on transfers of funds; export duties, quotas, and embargoes; domestic and international customs and tariffs; changing taxation policies; foreign exchange restrictions; political conditions; and governmental regulations. The following table presents the percentage of the Company's total production in Mexico and Canada: Three Months Ended March 31, 2022 2021 Mexico 25 % 23 % Canada 9 % 10 % The following table presents the percentage of the Company's total net sales represented by net sales from operations located in Mexico and Canada: Three Months Ended March 31, 2022 2021 Mexico 26 % 24 % Canada 9 % 10 % Labor Markets — At March 31, 2022, 49% of our employees were working in the United States, 48% were working in Mexico, and 3% were working in Canada. In the United States manufacturing facilities, 29% were covered under a collective bargaining agreement which expires in August 2022 while another 15% were covered under a separate collective bargaining agreement that expires in February 2023. |
New Accounting Pronouncements
New Accounting Pronouncements | 3 Months Ended |
Mar. 31, 2022 | |
Accounting Standards Update and Change in Accounting Principle [Abstract] | |
New Accounting Pronouncements | New Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-13, “Financial Instruments - Credit Losses,” which introduced new guidance for an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. Instruments in scope include loans, held-to-maturity debt securities, and net investments in leases as well as reinsurance and trade receivables. In November 2018, the FASB issued ASU 2018-19, which clarifies that operating lease receivables are outside the scope of the new standard. In November 2019, the FASB issued ASU 2019-10, which established the effective date of the new standard for smaller reporting companies as fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is evaluating the impact, if any, the adoption of the new credit losses model will have on its financial statements. In March 2020, the FASB issued ASU No. 2020-04 “Reference Rate Reform”. The ASU provides temporary optional guidance to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or any other reference rate expected to be discontinued. In January 2021, the FASB issued ASU 2021-01 - Reference Rate Reform (Topic 848). The amendments in this ASU clarify that certain option expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The ASU is intended to help stakeholders during the global market-wide reference rate transition period. Therefore, it will be in effect for a limited time through December 31, 2022. The Company is currently assessing which contracts may be affected. |
Revenues
Revenues | 3 Months Ended |
Mar. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenues | Revenues The following table presents the Company's net sales disaggregated by major sales channel: Three Months Ended March 31, 2022 2021 (dollars in thousands) Net Sales Transportation $ 31,449 $ 31,244 Appliance 3,124 3,135 Other 739 419 Total $ 35,312 $ 34,798 General Recognition Policy Revenue is recognized by the Company once all performance obligations under the terms of a contract with a Company's customer is satisfied. Generally this occurs with the transfer of control to a customer of its transportation, appliance, and other products. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring its products. The Company’s payment terms vary by the type and location of its customers and the products offered. The term between invoicing and when payment is due is not significant. In general for sales arrangements, the Company deems control to transfer at a single point in time and recognizes revenue when it ships products from its manufacturing facilities to its customers. Once a product has shipped, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. The Company considers control to transfer upon shipment because the Company has a present right to payment at that time, the customer has legal title to the asset, and the customer has significant risks and rewards of ownership of the asset. Contract Balances |
Inventory
Inventory | 3 Months Ended |
Mar. 31, 2022 | |
Inventory Disclosure [Abstract] | |
Inventory | Inventory Inventories consist of the following: March 31, 2022 December 31, 2021 (dollars in thousands) Raw materials $ 9,472 $ 9,242 Work in progress 1,195 990 Finished goods 2,810 3,538 Total inventory $ 13,477 $ 13,770 The Company periodically evaluates inventory for obsolescence, excess quantities, slow moving goods and other impairments of value and establishes reserves for any identified impairments. The allowance for obsolete inventory was $1.4 million at March 31, 2022 and $1.2 million at December 31, 2021. Included in inventory are assets located in Mexico with a carrying amount of $3.7 million at March 31, 2022 and $4.0 million at December 31, 2021, and assets located in Canada with a carrying amount of $1.2 million at March 31, 2022 and $1.1 million at December 31, 2021. |
Property, Plant, and Equipment,
Property, Plant, and Equipment, Net | 3 Months Ended |
Mar. 31, 2022 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant, and Equipment, Net | Property, Plant, and Equipment, Net Property, plant, and equipment, net consists of the following: March 31, 2022 December 31, 2021 Depreciable (dollars in thousands) Land $ 538 $ 538 Buildings 7,630 7,630 23 – 40 Shop equipment 26,108 26,049 7 – 10 Leasehold improvements 1,283 1,283 3 – 10 Office equipment 3,048 3,047 3 – 7 Mobile equipment 50 50 3 Construction in progress 1,724 1,554 Total cost 40,381 40,151 Less: Accumulated depreciation 18,400 17,584 Net property, plant, and equipment, net $ 21,981 $ 22,567 Depreciation expense was $0.8 million for the three months ended March 31, 2022, and $0.7 million for the three months ended March 31, 2021. Included in property, plant, and equipment, net are assets located in Mexico with a carrying amount of $3.5 million and $3.5 million at March 31, 2022 and December 31, 2021, respectively, and assets located in Canada with a carrying amount of $0.4 million and $0.4 million at March 31, 2022 and December 31, 2021, respectively. |
Long-term Debt
Long-term Debt | 3 Months Ended |
Mar. 31, 2022 | |
Debt Disclosure [Abstract] | |
Long-term Debt | Long-term Debt The Company’s long-term debt consists of the following: March 31, 2022 December 31, 2021 (dollars in thousands) US Term Loan, payable to lenders in quarterly installments of $0.8 million through November 7, 2023 with a lump sum due at maturity. The effective interest rate was 5.5% per annum at March 31, 2022 and December 31, 2021. At March 31, 2022, the balance of the US Term Loan is presented net of a debt discount of $113 thousand from costs paid to or on behalf of the lenders. $ 19,607 $ 20,383 CA Term Loan, payable to lenders in quarterly installments of $0.4 million through November 7, 2023, with a lump sum due at maturity. The effective interest rate was 5.5% per annum at March 31, 2022 and December 31, 2021. At March 31, 2022, the balance of the CA Term Loan is presented net of a debt discount of $49 thousand from costs paid to or on behalf of the lenders. 7,082 7,437 Capital expenditure line payable to lenders in quarterly installments of 12.5% per annum through November 7, 2023 with a lump sum due at maturity. The effective interest rate was 5.5% per annum at March 31, 2022 and December 31, 2021. 1,024 1,064 Total debt excluding Revolver $ 27,713 $ 28,884 As of March 31, 2022 and December 31, 2021, the fair value of the Company’s debt approximates book value based on the variable terms. Credit Agreement On November 8, 2018, Unique Fabricating NA, Inc. (the “US Borrower”) and Unique-Intasco Canada, Inc. (the “CA Borrower” and together with US Borrower, the “Borrowers”) and Citizens Bank, National Association (“Citizens”), acting as lender and Administrative Agent, and other lenders (collectively, the “Lenders”), entered into an Amended and Restated Credit Agreement (the “Credit Agreement”), which amended and restated the Original Credit Agreement entered into on April 29, 2016 (as amended, the “Original Credit Agreement”). The Credit Agreement is a five-year agreement and provided for borrowings up to an aggregate principal amount of $73.0 million. The Credit Agreement, which is a senior secured credit facility comprised of a revolving line of credit of up to $30.0 million (the “Revolver”) to the US Borrower, a $26.0 million principal amount term loan (the “US Term Loan”) to the US Borrower, a $12.0 million principal amount term loan (the “CA Term Loan”) to the CA Borrower, and a two-year line to fund capital expenditures of up to $2.5 million through November 8, 2019 and $5.0 million thereafter through November 8, 2020 to the US Borrower (the “Capital Expenditure Line”). The Credit Agreement has a maturity date for all borrowings of November 7, 2023. The Credit Agreement, as amended, bears interest at the Company’s election of either (i) the greater of the Prime Rate or the Federal Funds Effective Rate (the “Base Rate”) or (ii) the LIBOR rate, plus an applicable margin ranging from 1.75% to 3.25% per annum in the case of the Base Rate and 2.75% to 4.25% per annum in the case of the LIBOR rate, in each case, based on senior leverage ratio thresholds, measured quarterly, as increased by the Waiver and Fourth Amendment to the Credit Agreement. The Seventh Amendment to the Credit Agreement added a 1.0% LIBOR Floor and 2.0% Base Rate Floor. The First Amendment to the Forbearance Agreement increased the per annum interest rate from 4.25% to 4.50% for the duration of the Forbearance Period. Furthermore, the First Amendment imposes Payment in Kind (“PIK”) additional interest of 0.5% per annum on all outstanding debt subject to the Credit Agreement, which is payable on May 30, 2022, currently the termination date of the Forbearance Agreement, or earlier in the event of a Forbearance Termination event, as defined. As of March 31, 2022, $19.6 million was outstanding under the Revolver. This amount is gross of debt issuance costs which are further described in the next section. The Revolver had an effective interest rate of 5.50% percent per annum at March 31, 2022, and is secured by substantially all of the Company’s assets. At March 31, 2022, the maximum additional available borrowings under the Revolver was $5.2 million, which includes a reduction for a $0.1 million letter of credit issued for the benefit of the landlord of one of the Company’s leased facilities. The Company’s financial results for the six months ended December 31, 2020 and the nine months ended March 31, 2021 resulted in violations of one or more of the following financial covenants: (1) Maximum Total Leverage Ratio; (2) Minimum Debt Service Coverage Ratio; and (3) Minimum Consolidated EBITDA; as defined in the Company’s Credit Agreement. The Company entered into a Forbearance Agreement, providing a period commencing on April 9, 2021 and through and including June 15, 2021, during which the Company was able to borrow on its Revolver, subject to the terms and conditions to making a revolving credit advance, including availability, and the Lenders agreed, subject to the terms of the Forbearance Agreement, to forbear from enforcing their rights or seeking to collect payment of the Company’s debt or disposing of the collateral securing the debt. On June 14, 2021, the Company entered into the First Amendment to the Forbearance Agreement, which among other things, extended the forbearance period from June 15, 2021 to February 28, 2022 and waived the testing of the Maximum Total Leverage Ratio and Minimum Debt Service Coverage ratios for the duration of the Forbearance Period. The First Amendment also substituted Minimum Liquidity and Minimum Consolidated EBITDA requirements which would be tested monthly beginning with the month ending July 31, 2021. During the extended period, the Company was able to borrow under the revolving line of credit, subject to availability and satisfaction of certain other conditions. On September 21, 2021, the Company entered into the Second Amendment to Forbearance Agreement, which among other things, made changes to the calculations of financial covenants, contained revised requirements for Minimum Liquidity and Minimum Consolidated EBITDA, as defined, for the monthly periods through and including February 28, 2022, and revised the Revolving Credit Aggregate Commitment from $30 million to $27 million. On December 9, 2021, the Company entered into the Third Amendment to Forbearance Agreement. As previously reported, the Company was in violation of the required Minimum Consolidated EBITDA Covenant (as amended by the Second Amendment to the Forbearance Agreement) as of September 30, 2021. The Lenders in the Third Amendment to the Forbearance Agreement, among other things, agreed to forbear with respect to the Minimum Consolidated EBITDA covenant violation and to suspend the Minimum Consolidated EBITDA covenant during the remainder of the forbearance period. The Third Amendment includes a new covenant tested weekly on a rolling basis, beginning December 15, 2021, and required that the Company’s actual cumulative total cash disbursements for the period being tested to not exceed total cash disbursements projected by the Company for the same period by more than 15% at any time during the forbearance period. The Third Amendment also reduced the Revolving Credit Aggregate Commitment from $27 million to $25 million. As of December 31, 2021, the Company was in violation of the required minimum Liquidity covenant, as provided in the Second Amendment to the Forbearance Agreement, dated September 21, 2021. As a result, on February 4, 2022, the Company entered into the Fourth Amendment to Forbearance Agreement. The Lenders in the Fourth Amendment agreed to waive the minimum Liquidity covenant violation. The Company did have the required minimum liquidity by the conclusion of the first week of 2022. On February 25, 2022, the Company entered into the Fifth Amendment to Forbearance Agreement, which extends the Forbearance Period from February 28, 2022, to March 11, 2022. The Company used the short-term extension of its Forbearance Agreement, provided by the Fifth Amendment, to conduct negotiations of a longer extension with the Lenders. On March 11, 2022, the Company entered into the Sixth Amendment to Forbearance Agreement, which extends the Forbearance Period from March 11, 2022, to May 30, 2022. The Company intends to use the latest extension of its Forbearance Agreement, provided by the Sixth Amendment, to pursue a cure or waiver of financial covenant defaults and amended credit agreement. Debt Issuance Costs Debt issuance costs represent legal, consulting, and other financial costs associated with debt financing and are reported netted against the related debt instrument. Amounts paid to or on behalf of lenders are presented as a debt discount and are also shown as a reduction of the associated debt instrument. Debt issuance costs on term debt are amortized using the straight line basis over the term of the related debt (which is immaterially different from the required effective interest method) while those related to revolving debt are amortized using a straight line basis over the term of the related debt. At March 31, 2022 and December 31, 2021, unamortized debt issuance costs were $0.2 million and $0.2 million, respectively, while amounts paid to or on behalf of lenders presented as unamortized debt discounts were $0.2 million and $0.2 million, respectively. Amortization expense of both debt issuance costs and debt discounts has been recognized as a component of interest expense in the amounts of $0.1 million for the three months ended March 31, 2022, and $0.1 million for the three months ended March 31, 2021. Covenant Compliance The Amended and Restated Credit agreement, as further amended and forbore by the Forbearance Agreement, as amended, contains the following financial covenants: Maximum Total Leverage Ratio The Total Leverage Ratio, as defined in the Credit Agreement, as amended, may not exceed (i) 3.75 to 1.00, with respect to the fiscal quarter ended as of September 30, 2020; (ii) 3.50 to 1.00, with respect to the fiscal quarter ended December 31, 2020; (iii) 3.25 to 1.00, with respect to the fiscal quarters ended March 31, 2021 and June 30, 2021; and (iv) 3.00 to 1.00, with respect to each fiscal quarter thereafter. For purposes of calculating the Total Leverage Ratio, “Consolidated EBITDA”, as defined, shall be determined (i) with respect to the fiscal quarter ended as of September 30, 2020, for the single fiscal quarter then ended, multiplied by 4,(ii) with respect to the fiscal quarter ended as of December 31, 2020, for the two fiscal quarters then ended, multiplied by 2, (iii) with respect to the fiscal quarter ended as of March 31, 2021, for the three fiscal quarters then ended, multiplied by 4/3, and (iv) with respect to each fiscal quarter thereafter, for the four fiscal quarters then ended. Also, for purposes of calculating the Total Leverage Ratio, the PPP Note is excluded from Total Debt for all periods until a determination of forgiveness is made. However, testing of the Total Leverage Ratio is suspended during the Forbearance Period. Minimum Debt Service Coverage Ratio The Debt Service Coverage Ratio may not be less than 1.20 to 1.00, to be measured, as of the end of each fiscal quarter. Notwithstanding anything to the contrary set forth in the definition of "Debt Service Coverage Ratio," such calculation shall be made (i) with respect to the fiscal quarter ended as of September 30 2020, for the single fiscal quarter then ended, (ii) with respect to the fiscal quarter ended as of December 31, 2020, for the two fiscal quarters then ended, (iii) with respect to the fiscal quarter ended as of March 31, 2021, for the three fiscal quarters then ended, and (iv) with respect to the last day of each fiscal quarter thereafter, for the four fiscal quarters then ended. However, testing of the Minimum Debt Service Coverage Ratio is suspended during the Forbearance Period. Projected Cash Disbursements The Third Amendment to the Forbearance Agreement establishes a financial covenant limiting the Company’s cash disbursements for the duration of the Forbearance Period. Commencing on December 15, 2021, the cumulative total cash disbursements may not exceed the Company’s projected total cash disbursements for the same cumulative period by more than 15%. Future Maturities The loan covenant defaults mentioned previously, if not waived by our lenders, allows the lenders to accelerate the maturity of the debt, making it immediately due and payable. Accordingly, all debt subject to the Credit Agreement has been classified as current as of March 31, 2022: Future Maturities (dollars in thousands) 2022 $ 47,426 Total 47,426 Discounts (162) Debt issuance costs (215) Total debt, net $ 47,049 |
Derivative Financial Instrument
Derivative Financial Instruments | 3 Months Ended |
Mar. 31, 2022 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Financial Instruments | Derivative Financial Instruments Interest Rate Swap The Company holds a derivative financial instrument, in the form of an interest rate swap, as required by its Credit Agreement, for the purpose of hedging certain identifiable transactions in order to mitigate risks relating to the variability of future earnings and cash flows caused by interest rate fluctuations. The Company has elected not to apply hedge accounting for financial reporting purposes. The interest rate swap is recognized in the accompanying condensed consolidated balance sheets at its fair value. Monthly settlement payments due on the interest rate swap and changes in its fair value are recognized currently in net income as interest expense in the accompanying condensed consolidated statements of operations. Effective November 30, 2018, as required under the Amended and Restated Credit Agreement, the Company entered into an interest rate swap that requires the Company to pay a fixed rate of 3.075% per annum while receiving a variable interest rate per annum based on the one month LIBOR for a net monthly settlement based on the notional amount in effect. The notional amount at the effective date was $5.0 million, which increased by $0.4 million each quarter until June 28, 2019 when the notional amount increased to $17.5 million due to the interest rate swap from 2016 expiring. Since June 28, 2019, the notional amount then decreased each quarter by $0.2 million until September 30, 2020 when the notional amount increased to $17.5 million due to the interest rate swap from 2017 expiring. The notional amount then decreased each quarter by $0.4 million until December 31, 2021, then decreases each subsequent quarter by $0.6 million until it expires on November 8, 2023. At March 31, 2022, the fair value of all swaps was in a net liability position of $0.2 million and is included in other long term liabilities in the condensed consolidated balance sheets. At December 31, 2021, the fair value of the swap was $0.6 million. The Company paid $0.1 million in net monthly settlements with respect to the interest rate swaps for the three months ended March 31, 2022 and the three months ended March 31, 2021. Both the change in fair value and the net monthly settlements were included in interest expense in the condensed consolidated statements of operations. |
Stock Incentive Plans
Stock Incentive Plans | 3 Months Ended |
Mar. 31, 2022 | |
Share-based Payment Arrangement [Abstract] | |
Stock Incentive Plans | Stock Incentive Plans 2013 Stock Incentive Plan The Company’s board of directors approved a stock incentive plan (the “Plan”) in 2013. The Plan permits the Company to grant 495,000 non statutory or incentive stock options to the employees, directors and consultants of the Company. 495,000 shares of unissued common stock are reserved for the Plan. The board of directors has the authority to determine the participants to whom stock options shall be awarded as well as any restrictions to be placed upon the awards. The exercise price cannot be less than the fair value of the underlying shares at the time the stock options are issued and the maximum length of an award is ten years. 2014 Omnibus Performance Award Plan In 2014, the board of directors and stockholders adopted the Unique Fabricating, Inc. 2014 Omnibus Performance Award Plan, or the 2014 Plan. The 2014 Plan provides for the grant of cash awards, stock options, stock appreciation rights, or SARs, shares of restricted stock and restricted stock units, or RSUs, performance shares and performance units. The 2014 Plan originally authorized the grant of awards relating to 250,000 shares of our common stock. In the event of any transaction that causes a change in capitalization, the compensation committee, such other committee administering the 2014 Plan or the board of directors will make such adjustments to the number of shares of common stock delivered, and the number and/or price of shares of common stock subject to outstanding awards granted under the 2014 Plan, as it deems appropriate and equitable to prevent dilution or enlargement of participants’ rights. An amendment approved in March of 2016 by our board of directors which was approved by our stockholders at our annual meeting of stockholders in June 2016, increased the number of shares authorized for grant of awards under the 2014 Plan to a total of 450,000 shares of our common stock. In July 2020, an additional amendment was approved at our annual meeting of stockholders, which increased the number of shares authorized for grant of awards under the 2014 Plan to a total of 700,000 shares of our common stock. The fair value of each of the option awards is estimated on the grant date using a Black Scholes option pricing model that uses the weighted average assumptions noted in the following tables. The expected volatility is based on the historical volatility of the stock of comparable companies. The expected term of the awards was estimated based on findings from academic studies investigating the average holding period for options for adjusted for the Company’s size and risk factors. The risk free rate for periods within the contractual life of the option is based on the United States Treasury yield curve in effect at the time of grant. A summary of option activity under both plans is presented below: Number of Weighted Weighted Average Remaining Aggregate Intrinsic Value (1) (dollars in thousands, except share data and exercise price) Outstanding at December 31, 2021 846,731 $ 4.00 7.6 $ — Granted — $ — 0 $ — Exercised — $ — 0 $ — Forfeited or expired 13,647 $ 4.51 0 $ — Outstanding at March 31, 2022 833,084 $ 4.00 7.4 $ — Vested and exercisable at March 31, 2022 390,129 $ 4.81 6.4 $ — ———————————— (1) The aggregate intrinsic value above is obtained by subtracting the exercise price from the estimated fair value of the underlying shares and multiplying this result by the related number of options outstanding and exercisable as of the period end date. There is no intrinsic value if the exercise price exceeds the fair value of the underlying shares. The estimated fair value of the shares is based on the closing price of the stock of $1.90 as of March 31, 2022 and $1.96 as of December 31, 2021. The Company recorded stock-based compensation expense of $41 thousand for the three months ended March 31, 2022, respectively, and $27 thousand for the three months ended March 31, 2021, respectively. Stock compensation expense is included in the condensed consolidated statements of operations, as a component of selling, general, and administrative expenses. The income tax (expense) benefit related to share based compensation expense was immaterial for all periods presented. As of March 31, 2022, there was $577 thousand of total unrecognized compensation cost related to non-vested stock option awards under the plans. That cost is expected to be recognized over a weighted average period of 3.6 years. |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes For interim tax reporting we estimate our annual effective tax rate and apply it to our year to date income before income taxes. The tax effects of unusual or infrequently occurring items, including changes in judgment about valuation allowances and the effect of changes in tax laws or rates, are reported in the interim period in which they occur, if applicable. Income tax benefit for the three months ended March 31, 2022, was $(0.2) million, compared to income tax expense of $0.4 million for the three months ended March 31, 2021. During the three months ended March 31, 2022, the effective tax rate was 22%. The differences between the effective tax rates and the statutory rate of 21% were primarily related to a mix of earnings in jurisdictions which have higher income tax rates than the U.S. |
Leases
Leases | 3 Months Ended |
Mar. 31, 2022 | |
Leases [Abstract] | |
Leases | Leases The Company records a right-of-use (“ROU”) asset and lease liability for substantially all leases for which it is a lessee, in accordance with ASC 842. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the lease term. The Company has no significant lease agreements in place for which the Company is a lessor. At inception of a contract, the Company considers all relevant facts and circumstances to assess whether or not the contract represents a lease by determining whether or not the contract conveys the right to control the use of an identified asset, either explicit or implicit, for a period of time in exchange for consideration. The Company leases certain industrial spaces, office space, land, and equipment. Some leases include one or more options to renew, with renewal terms that can extend the lease term from generally one New leased assets obtained in exchange for new operating lease liabilities during the three months ended March 31, 2022 were immaterial. Prior to March 31, 2022, the Company signed a lease extension for one of the buildings in Queretaro, Mexico. This extension led to the Company recognizing an additional ROU asset and related liability of $0.4 million. Leased assets and liabilities included within the condensed consolidated balance sheets consist of the following: Classification March 31, 2022 (dollars in thousands) Right-of-Use-Assets Operating Operating leases $ 9,757 Liabilities Current Operating Other accrued liabilities $ 1,736 Non-current Operating Other liabilities 8,661 Total lease liabilities $ 10,397 Lease costs included in the condensed consolidated statements of operations consist of the following: Classification Three Months Ended March 31, 2022 (dollars in thousands) Lease cost Cost of sales, selling expenses and general and administrative expense $ 669 Maturities of the Company’s lease liabilities as of March 31, 2022 are as follows: Lease Liability Maturities (dollars in thousands) 2022 (remainder) $ 1,846 2023 1,931 2024 1,840 2025 1,702 2026 1,472 Thereafter 4,225 Total lease payments 13,016 Less: interest 2,619 Present value of lease payments $ 10,397 As most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. Remaining lease term and discount rates are as follows: March 31, 2022 Weighted average remaining lease term (years) 6.8 Weighted average discount rate 6.5 % Lease costs included in the condensed consolidated statements of cash flows are as follows: Three Months Ended March 31, 2022 (dollars in thousands) Cash paid for amounts included in the measurement of lease liabilities Operating cash outflows from operating leases $ 713 |
Retirement Plans
Retirement Plans | 3 Months Ended |
Mar. 31, 2022 | |
Retirement Benefits [Abstract] | |
Retirement Plans | Retirement PlansThe Company maintains a defined contribution plan covering certain full time salaried employees. Employees can make elective contributions to the plan. The Company contributes a match on 100% of an employee’s contribution up to the first 3% of each employee’s total compensation and 50% for the next 2% of each employee’s total compensation. In addition, the Company, at the discretion of the board of directors, may make additional contributions to the plan on behalf of the plan participants. The Company contributed $0.1 million for the three months ended March 31, 2022 and $0.1 million for the three months ended March 31, 2021. |
Related Party Transactions
Related Party Transactions | 3 Months Ended |
Mar. 31, 2022 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Related Party Transactions Effective March 18, 2013, the Company is a party to a management agreement with a firm related to several stockholders. The agreement initially provided for annual management fees of $300 thousand and additional fees for assistance provided with acquisitions. Effective upon completion of the Company's initial public offering, the agreement was amended to reduce the annual management fee by an amount equal to the amount, if any, of annual cash retainers and equity awards received as compensation for service on the board of directors to any person who is a related person of Taglich Private Equity, LLC or Taglich Brothers, Inc (“Taglich”). The Company incurred management fees of $56 thousand for the three months ended March 31, 2021, however, the Forbearance Agreement suspended any further management fee payments until the expiration of the Forbearance Period. The management agreement had an initial term of five years, expiring on March 18, 2020, and renews automatically annually for additional one year terms. The current term expires on March 18, 2023. The agreement also will terminate on the date that the Taglich Founding Investors or Taglich Equity Investors, each as defined, no longer also collectively own 50% of the equity securities owned by either of them on March 18, 2013. Beginning in February 2021, the Company began utilizing the services of Engauge Workforce Solutions LLC (“Engauge”), a manufacturing and distribution staffing agency. Ms. Kim Korth, a member of the Company’s Board of Directors, is also the Managing Director of Engauge. In March 2021, the Company entered into an agreement with Engauge for its services. The agreement is for an initial term of 12 months and will continue on a month-to-month basis after the initial term. The Company may terminate the agreement, without penalty, following the initial term with 60 days written notice. The Company has incurred fees for Engauge’s services for the three months ended March 31, 2022 of $350 thousand. |
Fair Value Measurements
Fair Value Measurements | 3 Months Ended |
Mar. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value MeasurementsFinancial instruments consist of cash equivalents, accounts receivable, accounts payable and debt. The carrying amount of all significant financial instruments approximates fair value due to either the short maturity or the existence of variable interest rates that approximate prevailing market rates. Accounting standards require certain other items be reported at fair value in the financial statements and provides a framework for establishing that fair value. The framework for determining fair value is based on a hierarchy that prioritizes the valuation techniques and inputs used to measure fair value. Fair values determined by Level 1 inputs use quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Fair values determined by Level 2 inputs use other inputs that are observable, either directly or indirectly. Level 2 inputs may include quoted prices for similar items in active markets, and other inputs such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related item. Level 3 fair value measurements are based primarily on management’s own estimates using inputs such as pricing models, discounted cash flow methodologies or similar techniques taking into account the characteristics of the item. In instances whereby inputs used to measure fair value fall into different levels of the fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company’s assessment of the significance of particular inputs to these fair value measurements requires judgment and considers factors specific to each item. The Company measures its interest rate swaps at fair value on a recurring basis based primarily on Level 2 inputs using an income model based on disparity between variable and fixed interest rates, the scheduled balance of principal outstanding, yield curves and other information readily available in the market. Please refer to Note 7 for more information on the Company’s interest rate swap. The Company assess goodwill for impairment on at least an annual basis, and more frequently whenever events or changes in circumstances indicate a potential impairment. The goodwill impairment analysis is based on Level 3 inputs, including forecasted EBITDA margins and future cash flows. |
Earnings Per Share
Earnings Per Share | 3 Months Ended |
Mar. 31, 2022 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | Earnings Per Share Basic earnings per share is computed by dividing the net income by the weighted-average number of shares outstanding during the period. Diluted earnings per share is computed giving effect to all potentially weighted average dilutive shares including stock options and warrants. The dilutive effect of outstanding awards, if any, is reflected in diluted earnings per share by application of the treasury stock method. The following table sets forth the reconciliation of the numerator and the denominator of basic and diluted loss per share: Three Months Ended March 31, 2022 2021 (dollars in thousands, except per share amounts) Numerator: Net income (loss) $ (569) $ (1,069) Denominator: Weighted average shares outstanding, basic 11,733,147 9,779,147 Dilutive effect of stock-based awards — — Weighted average share outstanding, diluted 11,733,147 9,779,147 Basic loss per share $ (0.05) $ (0.11) Diluted loss per share $ (0.05) $ (0.11) The effect of certain common stock equivalents were excluded from the computation of weighted average diluted shares outstanding for the three months ended March 31, 2022 and March 31, 2021, as inclusion would have resulted in anti-dilution. A summary of these anti-dilutive common stock equivalents is provided in the table below: Three Months Ended March 31, 2022 2021 Number of options 833,084 726,500 Exercise price of options $2.08 - $12.50 $2.36 - $12.58 Warrants (1) 156,320 Exercise price of warrants $3.12 _________________________________ |
Contingencies
Contingencies | 3 Months Ended |
Mar. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Contingencies | ContingenciesThe Company is engaged from time to time in legal matters and proceedings arising out of its normal course of business. The Company establishes a liability related to its legal proceedings and claims when it has determined that it is probable that the Company has incurred a liability and the related amount can be reasonably estimated. If the Company determines that an obligation is reasonably possible, the Company will, if material, disclose the nature of the loss contingency and the estimated range of possible loss, or include a statement that no estimate of loss can be made. While uncertainties are inherent in the final outcome of such matters, the Company believes that there are no pending proceedings in which the Company is currently involved that will have a material effect on its financial position, results of operations or cash flow. |
Nature of Business and Basis _2
Nature of Business and Basis of Presentation (Policies) | 3 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The Company’s condensed consolidated financial statements have been prepared without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the accompanying condensed consolidated financial statements contain all material adjustments (consisting only of normal recurring adjustments) necessary to present fairly the consolidated financial position of the Company, its results of operations, and its cash flows. The interim results for the periods presented may not be indicative of the Company's actual annual results. The condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Going Concern The Company’s condensed consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of December 31, 2020 and March 31, 2021, the Company was in violation of its financial covenants, as defined in the Company’s Credit Agreement ( Note 6 ). The Company entered into a forbearance agreement, dated April 9, 2021, which allowed the Company to be able to borrow on its revolving line of credit, subject to the terms and conditions to making a revolving credit advance, including availability, and the lenders agreed, subject to the terms of the forbearance agreement, as amended, to forbear from enforcing their rights or seeking to collect payment of the Company’s debt or disposing of the collateral securing the debt. As of September 30, 2021, the Company was also in violation of the required Minimum Consolidated EBITDA covenant (as amended by the Second Amendment to the Forbearance Agreement dated September 21, 2021). On December 9, 2021, the Company entered into the Third Amendment to Forbearance Agreement with respect to the Amended and Restated Credit Agreement, as amended. The Lenders in the Third Amendment to the Forbearance Agreement, among other things, agreed to forbear with respect to the Minimum Consolidated EBITDA covenant violation and to suspend the Minimum Consolidated EBITDA covenant during the remainder of the forbearance period. The Third Amendment included a new covenant that began on December 15, 2021, which is tested weekly on a rolling basis and requires that the Company’s actual cumulative total cash disbursements for the period being tested not exceed total cash disbursements projected by the Company for the same period by more than 15% at any time during the forbearance period. The Third Amendment also reduced the Revolving Credit Aggregate Commitment from $27 million to $25 million. As of December 31, 2021, the Company was in violation of the required Minimum Liquidity covenant, as provided in the Second Amendment to the Forbearance Agreement. As a result, on February 4, 2022, the Company entered into the Fourth Amendment to Forbearance Agreement. The Lenders in the Fourth Amendment to the Forbearance Agreement agreed to waive the Minimum Liquidity covenant violation. On February 25, 2022, the Company entered into the Fifth Amendment to Forbearance Agreement, which extends the Forbearance Period from February 28, 2022, to March 11, 2022. The Company used the short-term extension of its Forbearance Agreement, provided by the Fifth Amendment, to conduct negotiations of a longer extension with the Lenders. On March 11, 2022, the Company entered into the Sixth Amendment to Forbearance Agreement, which extends the Forbearance Period from March 11, 2022, to May 30, 2022. The Company intends to use the latest extension of its Forbearance Agreement, provided by the Sixth Amendment, to pursue a cure or waiver of financial covenant defaults and amended credit agreement The defaults, if not waived by our lenders, allows the lenders to accelerate the maturity of the debt, making it immediately due and payable. Accordingly, all debt subject to the Credit Agreement, totaling $47.0 million, has been classified as current as of March 31, 2022. The Company does not have sufficient cash and cash equivalents on hand or available liquidity to repay such debt or meet its obligations as they become due through twelve months from date of issuance of these condensed consolidated financial statements. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. In response to these conditions, the Company is discussing with its bank lenders entering into an amendment and waiver to cure the covenant defaults. There is not any assurance that the lenders will waive such non compliance or agree to an amendment to the current provisions. Even if the lenders were to agree to waive the failures to comply as of December 31, 2020, March 31, 2021, and September 30, 2021, there cannot be any assurance that, at any future date at which compliance is measured, we will be able to comply with the covenants contained in the forbearance agreement, as amended, given the industry-wide and other challenges that we face, as described elsewhere herein, or that our lenders would waive a default if that were to occur. Furthermore, there can be no assurance that the Company will be able to enter into an amendment or waiver with the lenders or if it enters into an amendment, what the terms, restrictions, and covenants of the amendment will contain. These plans have not been finalized and are not within the Company’s control, and therefore cannot be deemed probable. As a result, the Company has concluded that management’s plans do not alleviate substantial doubt about the Company’s ability to continue as a going concern. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. |
New Accounting Pronouncements | In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-13, “Financial Instruments - Credit Losses,” which introduced new guidance for an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. Instruments in scope include loans, held-to-maturity debt securities, and net investments in leases as well as reinsurance and trade receivables. In November 2018, the FASB issued ASU 2018-19, which clarifies that operating lease receivables are outside the scope of the new standard. In November 2019, the FASB issued ASU 2019-10, which established the effective date of the new standard for smaller reporting companies as fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is evaluating the impact, if any, the adoption of the new credit losses model will have on its financial statements. In March 2020, the FASB issued ASU No. 2020-04 “Reference Rate Reform”. The ASU provides temporary optional guidance to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or any other reference rate expected to be discontinued. In January 2021, the FASB issued ASU 2021-01 - Reference Rate Reform (Topic 848). The amendments in this ASU clarify that certain option expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The ASU is intended to help stakeholders during the global market-wide reference rate transition period. Therefore, it will be in effect for a limited time through December 31, 2022. The Company is currently assessing which contracts may be affected. |
Revenue Recognition | Revenue is recognized by the Company once all performance obligations under the terms of a contract with a Company's customer is satisfied. Generally this occurs with the transfer of control to a customer of its transportation, appliance, and other products. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring its products. The Company’s payment terms vary by the type and location of its customers and the products offered. The term between invoicing and when payment is due is not significant. In general for sales arrangements, the Company deems control to transfer at a single point in time and recognizes revenue when it ships products from its manufacturing facilities to its customers. Once a product has shipped, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. The Company considers control to transfer upon shipment because the Company has a present right to payment at that time, the customer has legal title to the asset, and the customer has significant risks and rewards of ownership of the asset. Contract Balances |
Fair Value Measurement | Financial instruments consist of cash equivalents, accounts receivable, accounts payable and debt. The carrying amount of all significant financial instruments approximates fair value due to either the short maturity or the existence of variable interest rates that approximate prevailing market rates. Accounting standards require certain other items be reported at fair value in the financial statements and provides a framework for establishing that fair value. The framework for determining fair value is based on a hierarchy that prioritizes the valuation techniques and inputs used to measure fair value. Fair values determined by Level 1 inputs use quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Fair values determined by Level 2 inputs use other inputs that are observable, either directly or indirectly. Level 2 inputs may include quoted prices for similar items in active markets, and other inputs such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related item. Level 3 fair value measurements are based primarily on management’s own estimates using inputs such as pricing models, discounted cash flow methodologies or similar techniques taking into account the characteristics of the item. In instances whereby inputs used to measure fair value fall into different levels of the fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company’s assessment of the significance of particular inputs to these fair value measurements requires judgment and considers factors specific to each item. The Company measures its interest rate swaps at fair value on a recurring basis based primarily on Level 2 inputs using an income model based on disparity between variable and fixed interest rates, the scheduled balance of principal outstanding, yield curves and other information readily available in the market. Please refer to Note 7 for more information on the Company’s interest rate swap. The Company assess goodwill for impairment on at least an annual basis, and more frequently whenever events or changes in circumstances indicate a potential impairment. The goodwill impairment analysis is based on Level 3 inputs, including forecasted EBITDA margins and future cash flows. |
Nature of Business and Basis _3
Nature of Business and Basis of Presentation (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Schedules of Concentration of Risk | The following table presents the Company's sales directly to General Motors Company (“GM”), Yanfeng Automotive Interiors, Stellantis N.V. (formerly Fiat Chrysler Automobiles), and Ford Motor Company (“Ford”) as a percentage of total net sales: Three Months Ended March 31, 2022 2021 General Motors Company 9 % 7 % Yanfeng Automotive Interiors 10 % 7 % Stellantis N.V. 8 % 6 % Ford Motor Company 5 % 5 % Three Months Ended March 31, 2022 2021 Mexico 25 % 23 % Canada 9 % 10 % The following table presents the percentage of the Company's total net sales represented by net sales from operations located in Mexico and Canada: Three Months Ended March 31, 2022 2021 Mexico 26 % 24 % Canada 9 % 10 % |
Revenues (Tables)
Revenues (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue | The following table presents the Company's net sales disaggregated by major sales channel: Three Months Ended March 31, 2022 2021 (dollars in thousands) Net Sales Transportation $ 31,449 $ 31,244 Appliance 3,124 3,135 Other 739 419 Total $ 35,312 $ 34,798 |
Inventory (Tables)
Inventory (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventory | Inventories consist of the following: March 31, 2022 December 31, 2021 (dollars in thousands) Raw materials $ 9,472 $ 9,242 Work in progress 1,195 990 Finished goods 2,810 3,538 Total inventory $ 13,477 $ 13,770 |
Property, Plant, and Equipmen_2
Property, Plant, and Equipment, Net (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property, Plant and Equipment | Property, plant, and equipment, net consists of the following: March 31, 2022 December 31, 2021 Depreciable (dollars in thousands) Land $ 538 $ 538 Buildings 7,630 7,630 23 – 40 Shop equipment 26,108 26,049 7 – 10 Leasehold improvements 1,283 1,283 3 – 10 Office equipment 3,048 3,047 3 – 7 Mobile equipment 50 50 3 Construction in progress 1,724 1,554 Total cost 40,381 40,151 Less: Accumulated depreciation 18,400 17,584 Net property, plant, and equipment, net $ 21,981 $ 22,567 |
Long-term Debt (Tables)
Long-term Debt (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Debt Disclosure [Abstract] | |
Schedule of Long-Term Debt | The Company’s long-term debt consists of the following: March 31, 2022 December 31, 2021 (dollars in thousands) US Term Loan, payable to lenders in quarterly installments of $0.8 million through November 7, 2023 with a lump sum due at maturity. The effective interest rate was 5.5% per annum at March 31, 2022 and December 31, 2021. At March 31, 2022, the balance of the US Term Loan is presented net of a debt discount of $113 thousand from costs paid to or on behalf of the lenders. $ 19,607 $ 20,383 CA Term Loan, payable to lenders in quarterly installments of $0.4 million through November 7, 2023, with a lump sum due at maturity. The effective interest rate was 5.5% per annum at March 31, 2022 and December 31, 2021. At March 31, 2022, the balance of the CA Term Loan is presented net of a debt discount of $49 thousand from costs paid to or on behalf of the lenders. 7,082 7,437 Capital expenditure line payable to lenders in quarterly installments of 12.5% per annum through November 7, 2023 with a lump sum due at maturity. The effective interest rate was 5.5% per annum at March 31, 2022 and December 31, 2021. 1,024 1,064 Total debt excluding Revolver $ 27,713 $ 28,884 |
Schedule of Maturities of Long-Term Debt | Accordingly, all debt subject to the Credit Agreement has been classified as current as of March 31, 2022: Future Maturities (dollars in thousands) 2022 $ 47,426 Total 47,426 Discounts (162) Debt issuance costs (215) Total debt, net $ 47,049 |
Stock Incentive Plans (Tables)
Stock Incentive Plans (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Share-based Payment Arrangement [Abstract] | |
Schedule of Stock Options and Stock Appreciation Rights Award Activity | A summary of option activity under both plans is presented below: Number of Weighted Weighted Average Remaining Aggregate Intrinsic Value (1) (dollars in thousands, except share data and exercise price) Outstanding at December 31, 2021 846,731 $ 4.00 7.6 $ — Granted — $ — 0 $ — Exercised — $ — 0 $ — Forfeited or expired 13,647 $ 4.51 0 $ — Outstanding at March 31, 2022 833,084 $ 4.00 7.4 $ — Vested and exercisable at March 31, 2022 390,129 $ 4.81 6.4 $ — ———————————— |
Leases (Tables)
Leases (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Leases [Abstract] | |
Balance Sheet and Weighted-Average Lease Information | Leased assets and liabilities included within the condensed consolidated balance sheets consist of the following: Classification March 31, 2022 (dollars in thousands) Right-of-Use-Assets Operating Operating leases $ 9,757 Liabilities Current Operating Other accrued liabilities $ 1,736 Non-current Operating Other liabilities 8,661 Total lease liabilities $ 10,397 March 31, 2022 Weighted average remaining lease term (years) 6.8 Weighted average discount rate 6.5 % |
Lease Cost Information | Lease costs included in the condensed consolidated statements of operations consist of the following: Classification Three Months Ended March 31, 2022 (dollars in thousands) Lease cost Cost of sales, selling expenses and general and administrative expense $ 669 Lease costs included in the condensed consolidated statements of cash flows are as follows: Three Months Ended March 31, 2022 (dollars in thousands) Cash paid for amounts included in the measurement of lease liabilities Operating cash outflows from operating leases $ 713 |
Lease Maturity | Maturities of the Company’s lease liabilities as of March 31, 2022 are as follows: Lease Liability Maturities (dollars in thousands) 2022 (remainder) $ 1,846 2023 1,931 2024 1,840 2025 1,702 2026 1,472 Thereafter 4,225 Total lease payments 13,016 Less: interest 2,619 Present value of lease payments $ 10,397 |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | The following table sets forth the reconciliation of the numerator and the denominator of basic and diluted loss per share: Three Months Ended March 31, 2022 2021 (dollars in thousands, except per share amounts) Numerator: Net income (loss) $ (569) $ (1,069) Denominator: Weighted average shares outstanding, basic 11,733,147 9,779,147 Dilutive effect of stock-based awards — — Weighted average share outstanding, diluted 11,733,147 9,779,147 Basic loss per share $ (0.05) $ (0.11) Diluted loss per share $ (0.05) $ (0.11) |
Schedule of Antidilutive Securities Excluded from Computation of Earnings per Share | A summary of these anti-dilutive common stock equivalents is provided in the table below: Three Months Ended March 31, 2022 2021 Number of options 833,084 726,500 Exercise price of options $2.08 - $12.50 $2.36 - $12.58 Warrants (1) 156,320 Exercise price of warrants $3.12 _________________________________ |
Nature of Business and Basis _4
Nature of Business and Basis of Presentation - Additional Information (Details) | Dec. 09, 2021USD ($) | Mar. 31, 2022USD ($)segment | Dec. 31, 2021USD ($) | Dec. 08, 2021USD ($) | Sep. 21, 2021USD ($) | Sep. 20, 2021USD ($) |
Concentration Risk [Line Items] | ||||||
Number of reportable segments | segment | 1 | |||||
Revolver, current maturities | $ 19,336,000 | $ 19,541,000 | ||||
Labor Force Concentration Risk | Workforce Subject to Collective Bargaining Arrangements | Collective Bargaining Arrangements Expiring August 2022 | ||||||
Concentration Risk [Line Items] | ||||||
Concentration risk (percentage) | 29.00% | |||||
Labor Force Concentration Risk | Workforce Subject to Collective Bargaining Arrangements | Collective Bargaining Arrangements Expiring February 2023 | ||||||
Concentration Risk [Line Items] | ||||||
Concentration risk (percentage) | 15.00% | |||||
Labor Force Concentration Risk | Workforce Subject to Collective Bargaining Arrangements | United States | ||||||
Concentration Risk [Line Items] | ||||||
Concentration risk (percentage) | 49.00% | |||||
Labor Force Concentration Risk | Workforce Subject to Collective Bargaining Arrangements | Mexico | ||||||
Concentration Risk [Line Items] | ||||||
Concentration risk (percentage) | 48.00% | |||||
Labor Force Concentration Risk | Workforce Subject to Collective Bargaining Arrangements | Canada | ||||||
Concentration Risk [Line Items] | ||||||
Concentration risk (percentage) | 3.00% | |||||
Revolving credit facility | Line of Credit | ||||||
Concentration Risk [Line Items] | ||||||
Maximum borrowing capacity | $ 25,000,000 | $ 27,000,000 | $ 27,000,000 | $ 30,000,000 | ||
Forbearance Agreement | Line of Credit | ||||||
Concentration Risk [Line Items] | ||||||
Total cash disbursements | 15.00% | |||||
Credit agreement | ||||||
Concentration Risk [Line Items] | ||||||
Revolver, current maturities | $ 47,000,000 |
Nature of Business and Basis _5
Nature of Business and Basis of Presentation - Customers' Net Sales as a Percentage of Total Net Sales (Details) - Sales Revenue, Net - Customer Concentration Risk | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
General Motors Company | ||
Product Information [Line Items] | ||
Concentration risk (percentage) | 9.00% | 7.00% |
Yanfeng Automotive Interiors | ||
Product Information [Line Items] | ||
Concentration risk (percentage) | 10.00% | 7.00% |
Stellantis N.V. | ||
Product Information [Line Items] | ||
Concentration risk (percentage) | 8.00% | 6.00% |
Ford Motor Company | ||
Product Information [Line Items] | ||
Concentration risk (percentage) | 5.00% | 5.00% |
Nature of Business and Basis _6
Nature of Business and Basis of Presentation - Production in Foreign Markets (Details) - Geographic Concentration Risk | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Mexico | Cost of Goods and Service Benchmark | ||
Product Information [Line Items] | ||
Concentration risk (percentage) | 25.00% | 23.00% |
Mexico | Sales Revenue, Net | ||
Product Information [Line Items] | ||
Concentration risk (percentage) | 26.00% | 24.00% |
Canada | Cost of Goods and Service Benchmark | ||
Product Information [Line Items] | ||
Concentration risk (percentage) | 9.00% | 10.00% |
Canada | Sales Revenue, Net | ||
Product Information [Line Items] | ||
Concentration risk (percentage) | 9.00% | 10.00% |
Revenues (Details)
Revenues (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Disaggregation of Revenue [Line Items] | ||
Total sales | $ 35,312 | $ 34,798 |
Transportation | ||
Disaggregation of Revenue [Line Items] | ||
Total sales | 31,449 | 31,244 |
Appliance | ||
Disaggregation of Revenue [Line Items] | ||
Total sales | 3,124 | 3,135 |
Other | ||
Disaggregation of Revenue [Line Items] | ||
Total sales | $ 739 | $ 419 |
Inventory - Schedule of Invento
Inventory - Schedule of Inventory (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Inventory Disclosure [Abstract] | ||
Raw materials | $ 9,472 | $ 9,242 |
Work in progress | 1,195 | 990 |
Finished goods | 2,810 | 3,538 |
Total inventory | $ 13,477 | $ 13,770 |
Inventory - Additional Informat
Inventory - Additional Information (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Inventory [Line Items] | ||
Allowance for obsolete inventory | $ 1,400 | $ 1,200 |
Inventory, net | 13,477 | 13,770 |
Mexico | ||
Inventory [Line Items] | ||
Inventory, net | 3,700 | 4,000 |
Canada | ||
Inventory [Line Items] | ||
Inventory, net | $ 1,200 | $ 1,100 |
Property, Plant, and Equipmen_3
Property, Plant, and Equipment, Net - Schedule of Property, Plant, and Equipment (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Dec. 31, 2021 | |
Property, Plant and Equipment [Line Items] | ||
Total cost | $ 40,381 | $ 40,151 |
Less: Accumulated depreciation | 18,400 | 17,584 |
Net property, plant, and equipment, net | 21,981 | 22,567 |
Land | ||
Property, Plant and Equipment [Line Items] | ||
Total cost | 538 | 538 |
Buildings | ||
Property, Plant and Equipment [Line Items] | ||
Total cost | $ 7,630 | 7,630 |
Buildings | Minimum | ||
Property, Plant and Equipment [Line Items] | ||
Depreciable Life – Years | 23 years | |
Buildings | Maximum | ||
Property, Plant and Equipment [Line Items] | ||
Depreciable Life – Years | 40 years | |
Shop equipment | ||
Property, Plant and Equipment [Line Items] | ||
Total cost | $ 26,108 | 26,049 |
Shop equipment | Minimum | ||
Property, Plant and Equipment [Line Items] | ||
Depreciable Life – Years | 7 years | |
Shop equipment | Maximum | ||
Property, Plant and Equipment [Line Items] | ||
Depreciable Life – Years | 10 years | |
Leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Total cost | $ 1,283 | 1,283 |
Leasehold improvements | Minimum | ||
Property, Plant and Equipment [Line Items] | ||
Depreciable Life – Years | 3 years | |
Leasehold improvements | Maximum | ||
Property, Plant and Equipment [Line Items] | ||
Depreciable Life – Years | 10 years | |
Office equipment | ||
Property, Plant and Equipment [Line Items] | ||
Total cost | $ 3,048 | 3,047 |
Office equipment | Minimum | ||
Property, Plant and Equipment [Line Items] | ||
Depreciable Life – Years | 3 years | |
Office equipment | Maximum | ||
Property, Plant and Equipment [Line Items] | ||
Depreciable Life – Years | 7 years | |
Mobile equipment | ||
Property, Plant and Equipment [Line Items] | ||
Total cost | $ 50 | 50 |
Depreciable Life – Years | 3 years | |
Construction in progress | ||
Property, Plant and Equipment [Line Items] | ||
Total cost | $ 1,724 | $ 1,554 |
Property, Plant, and Equipmen_4
Property, Plant, and Equipment, Net - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Dec. 31, 2021 | |
Property, Plant and Equipment [Line Items] | |||
Depreciation expense | $ 800 | $ 700 | |
Property, plant, and equipment, net | 21,981 | $ 22,567 | |
Mexico | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant, and equipment, net | 3,500 | 3,500 | |
Canada | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant, and equipment, net | $ 400 | $ 400 |
Long-term Debt - Schedule of Lo
Long-term Debt - Schedule of Long-Term Debt (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Dec. 31, 2021 | |
Debt Instrument [Line Items] | ||
Debt discount | $ 162 | $ 200 |
Outstanding principal amount | $ 27,713 | $ 28,884 |
Line of Credit | New US Term Loan | Secured Debt | ||
Debt Instrument [Line Items] | ||
Effective interest rate | 5.50% | 5.50% |
Debt discount | $ 113 | |
Outstanding principal amount | 19,607 | $ 20,383 |
Line of Credit | New US Term Loan | Secured Debt | October 1, 2021 Through November 7, 2023 | ||
Debt Instrument [Line Items] | ||
Principal payment | $ 800 | |
Line of Credit | CA term loan | Secured Debt | ||
Debt Instrument [Line Items] | ||
Effective interest rate | 5.50% | 5.50% |
Debt discount | $ 49 | |
Outstanding principal amount | 7,082 | $ 7,437 |
Line of Credit | CA term loan | Secured Debt | October 1, 2021 Through November 7, 2023 | ||
Debt Instrument [Line Items] | ||
Principal payment | $ 400 | |
Line of Credit | Capital expenditure line | ||
Debt Instrument [Line Items] | ||
Effective interest rate | 5.50% | 5.50% |
Outstanding principal amount | $ 1,024 | $ 1,064 |
Line of Credit | Capital expenditure line | October 1, 2021 Through November 7, 2023 | ||
Debt Instrument [Line Items] | ||
Percent of principal payment | 12.50% |
Long-term Debt - Additional Inf
Long-term Debt - Additional Information (Details) - USD ($) | Mar. 31, 2022 | Dec. 09, 2021 | Nov. 08, 2018 | Mar. 31, 2022 | Mar. 31, 2021 | Dec. 31, 2021 | Dec. 08, 2021 | Sep. 21, 2021 | Sep. 20, 2021 |
Debt Instrument [Line Items] | |||||||||
Outstanding principal amount | $ 27,713,000 | $ 27,713,000 | $ 28,884,000 | ||||||
Debt issuance cost | 200,000 | 200,000 | 200,000 | ||||||
Unamortized discount | $ 162,000 | 162,000 | 200,000 | ||||||
Amortization expense of debt issuance costs | $ 100,000 | $ 100,000 | |||||||
Amended and Restated Credit Agreement | |||||||||
Debt Instrument [Line Items] | |||||||||
Minimum debt service coverage ratio | 1.20 | 1.20 | |||||||
Amended and Restated Credit Agreement | Fiscal Quarter Ending September 30, 2020 | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt instrument, total covenant, leverage ratio | 3.75 | 3.75 | |||||||
Debt instrument, covenant, multiplier | 400.00% | ||||||||
Amended and Restated Credit Agreement | Fiscal Quarter Ending December 31, 2020 | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt instrument, total covenant, leverage ratio | 3.50 | 3.50 | |||||||
Debt instrument, covenant, multiplier | 200.00% | ||||||||
Amended and Restated Credit Agreement | Fiscal Quarter Ending March 31, 2021 | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt instrument, total covenant, leverage ratio | 3.25 | 3.25 | |||||||
Debt instrument, covenant, multiplier | 133.30% | ||||||||
Amended and Restated Credit Agreement | Fiscal Quarter Ending June 30, 2021 | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt instrument, total covenant, leverage ratio | 3.25 | 3.25 | |||||||
Amended and Restated Credit Agreement | Fiscal Quarter Thereafter | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt instrument, total covenant, leverage ratio | 3 | 3 | |||||||
Forbearance Agreement | Trailing 12 Months | |||||||||
Debt Instrument [Line Items] | |||||||||
Limit to the excess above projected total cash disbursements (percent) | 15.00% | 15.00% | |||||||
Forbearance Agreement | Line of Credit | |||||||||
Debt Instrument [Line Items] | |||||||||
Total cash disbursements | 15.00% | ||||||||
Line of Credit | Amended and Restated Credit Agreement | Secured Debt | |||||||||
Debt Instrument [Line Items] | |||||||||
Maximum borrowing capacity | $ 73,000,000 | ||||||||
Line of Credit | Amended and Restated Credit Agreement | Secured Debt | Minimum | Base Rate | PPP under CARES Act | |||||||||
Debt Instrument [Line Items] | |||||||||
Basis spread on variable rate | 2.00% | ||||||||
Line of Credit | Amended and Restated Credit Agreement | Secured Debt | Minimum | LIBOR | PPP under CARES Act | |||||||||
Debt Instrument [Line Items] | |||||||||
Basis spread on variable rate | 1.00% | ||||||||
Line of Credit | Amended and Restated Credit Agreement | US Borrower and CA Borrower | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt instrument, term | 5 years | ||||||||
Debt instrument, term to fund capital expenditures | 2 years | ||||||||
Line of Credit | Amended and Restated Credit Agreement | US Borrower and CA Borrower | Revolving credit facility | |||||||||
Debt Instrument [Line Items] | |||||||||
Maximum borrowing capacity | $ 30,000,000 | ||||||||
Line of Credit | US Term loan | US Borrower and CA Borrower | Secured Debt | |||||||||
Debt Instrument [Line Items] | |||||||||
Maximum increase to principal amount | 26,000,000 | ||||||||
Line of Credit | CA term loan | Secured Debt | |||||||||
Debt Instrument [Line Items] | |||||||||
Outstanding principal amount | $ 7,082,000 | $ 7,082,000 | $ 7,437,000 | ||||||
Effective interest rate | 5.50% | 5.50% | 5.50% | ||||||
Unamortized discount | $ 49,000 | $ 49,000 | |||||||
Line of Credit | CA term loan | US Borrower and CA Borrower | Secured Debt | |||||||||
Debt Instrument [Line Items] | |||||||||
Outstanding principal amount | $ 12,000,000 | ||||||||
Line of Credit | Credit agreement | Secured Debt | Minimum | Base Rate | |||||||||
Debt Instrument [Line Items] | |||||||||
Basis spread on variable rate | 1.75% | ||||||||
Line of Credit | Credit agreement | Secured Debt | Minimum | LIBOR | |||||||||
Debt Instrument [Line Items] | |||||||||
Basis spread on variable rate | 2.75% | ||||||||
Line of Credit | Credit agreement | Secured Debt | Maximum | Base Rate | |||||||||
Debt Instrument [Line Items] | |||||||||
Basis spread on variable rate | 3.25% | ||||||||
Line of Credit | Credit agreement | Secured Debt | Maximum | LIBOR | |||||||||
Debt Instrument [Line Items] | |||||||||
Basis spread on variable rate | 4.25% | ||||||||
Line of Credit | First Amendment To Forbearance Agreement | Secured Debt | LIBOR | |||||||||
Debt Instrument [Line Items] | |||||||||
Basis spread on variable rate | 4.50% | 4.25% | |||||||
Line of Credit | Forbearance Agreement | Secured Debt | |||||||||
Debt Instrument [Line Items] | |||||||||
Paid-in-kind percentage | 0.50% | 0.50% | |||||||
Revolving credit facility | Line of Credit | |||||||||
Debt Instrument [Line Items] | |||||||||
Maximum borrowing capacity | $ 25,000,000 | $ 27,000,000 | $ 27,000,000 | $ 30,000,000 | |||||
Revolving credit facility | New Revolver | Line of Credit | |||||||||
Debt Instrument [Line Items] | |||||||||
Line of credit | $ 19,600,000 | $ 19,600,000 | |||||||
Effective interest rate | 5.50% | 5.50% | |||||||
Remaining borrowing capacity | $ 5,200,000 | $ 5,200,000 | |||||||
Capital expenditure line | Amended and Restated Credit Agreement | US Borrower and CA Borrower | November 8, 2018 Through November 8, 2019 | |||||||||
Debt Instrument [Line Items] | |||||||||
Maximum borrowing capacity | $ 2,500,000 | ||||||||
Capital expenditure line | Amended and Restated Credit Agreement | US Borrower and CA Borrower | November 9, 2019 Through November 8, 2020 | |||||||||
Debt Instrument [Line Items] | |||||||||
Maximum borrowing capacity | $ 5,000,000 | ||||||||
Letter of credit | New Revolver | Line of Credit | |||||||||
Debt Instrument [Line Items] | |||||||||
Letters of credit outstanding, amount | $ 100,000 | $ 100,000 |
Long-term Debt - Schedule of Re
Long-term Debt - Schedule of Repayment of Maturities (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Debt Disclosure [Abstract] | ||
2022 | $ 47,426 | |
Total | 47,426 | |
Discounts | (162) | $ (200) |
Debt issuance costs | (215) | |
Total debt, net | $ 47,049 |
Derivative Financial Instrume_2
Derivative Financial Instruments (Details) - Interest Rate Swap - Not Designated as Hedging Instrument - USD ($) | 3 Months Ended | |||
Mar. 31, 2022 | Mar. 31, 2021 | Dec. 31, 2021 | Nov. 30, 2018 | |
Derivatives, Fair Value [Line Items] | ||||
Fixed interest rate | 3.075% | |||
Notional amount | $ 5,000,000 | |||
Derivative net liability | $ 200,000 | $ 600,000 | ||
Interest Expense | ||||
Derivatives, Fair Value [Line Items] | ||||
Monthly settlement payments (receipts) | $ 100,000 | $ 100,000 | ||
Derivative Instrument, Periodic Payment, Installment Periods Through June Twenty Eight Two Thousand Nineteen | ||||
Derivatives, Fair Value [Line Items] | ||||
Notional amount | 17,500,000 | |||
Quarterly increase in notional amount | 400,000 | |||
Derivative Instrument, Periodic Payment, Installment Periods Until September Thirty Two Thousand Twenty | ||||
Derivatives, Fair Value [Line Items] | ||||
Notional amount | 17,500,000 | |||
Quarterly decrease in notional amount | 200,000 | |||
Derivative Instrument, Periodic Payment, Installment Periods Until November Eighth Twenty Twenty Three | ||||
Derivatives, Fair Value [Line Items] | ||||
Quarterly decrease in notional amount | 600,000 | |||
Derivative Instrument, Periodic Payment, Installment Periods Until December 31, 2021 | ||||
Derivatives, Fair Value [Line Items] | ||||
Quarterly decrease in notional amount | $ 400,000 |
Stock Incentive Plans - Additio
Stock Incentive Plans - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | ||||
Mar. 31, 2022 | Mar. 31, 2021 | Dec. 29, 2013 | Jul. 31, 2020 | Jun. 30, 2016 | Jan. 04, 2015 | |
Selling, General and Administrative Expenses | ||||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||||
Allocated share-based compensation expense | $ 41 | $ 27 | ||||
Employee Stock Option | ||||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||||
Unrecognized compensation cost | $ 577 | |||||
Compensation cost, weighted average period | 3 years 7 months 6 days | |||||
The 2013 Stock Incentive Plan | ||||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||||
Number of shares reserved for future issuance (in shares) | 495,000 | |||||
The 2013 Stock Incentive Plan | Employee Stock Option | ||||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||||
Number of shares available for grant (in shares) | 495,000 | |||||
Expiration period | 10 years | |||||
2014 Omnibus Performance Award Plan | ||||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||||
Number of shares authorized (in shares) | 700,000 | 450,000 | 250,000 |
Stock Incentive Plans - Schedul
Stock Incentive Plans - Schedule of Stock Options and Stock Awards (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2022 | Dec. 31, 2021 | |
Number of Shares | ||
Outstanding at end of period (in shares) | 833,084 | |
Aggregate Intrinsic Value | ||
Share price (in dollars per share) | $ 1.90 | $ 1.96 |
The Plan and the 2014 Plan | ||
Number of Shares | ||
Outstanding at beginning of period (in shares) | 846,731 | |
Granted (in shares) | 0 | |
Exercised (in shares) | 0 | |
Forfeited or expired (in shares) | 13,647 | |
Outstanding at end of period (in shares) | 833,084 | 846,731 |
Vested and exercisable (in shares) | 390,129 | |
Weighted Average Exercise Price | ||
Outstanding at beginning of period (in dollars per share) | $ 4 | |
Granted (in dollars per share) | 0 | |
Exercised (in dollars per share) | 0 | |
Forfeited or expired (in dollars per share) | 4.51 | |
Outstanding at end of period (in dollars per share) | 4 | $ 4 |
Vested and exercisable (in dollars per share) | $ 4.81 | |
Weighted Average Remaining Contractual Term (in years) | ||
Outstanding weighted average remaining contractual term | 7 years 4 months 24 days | 7 years 7 months 6 days |
Granted | 0 years | |
Exercised | 0 years | |
Forfeited or expired | 0 years | |
Vested and exercisable | 6 years 4 months 24 days | |
Aggregate Intrinsic Value | ||
Outstanding, beginning of period (in shares) | 0 | |
Forfeited or expired (in shares) | 0 | |
Outstanding, end of period (in shares) | $ 0 | |
Vested and exercisable at end of period (in shares) | $ 0 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Income Tax Disclosure [Abstract] | ||
Income tax expense (benefit) | $ (165) | $ 442 |
Actual effective rate (percent) | 22.00% |
Leases - Additional Information
Leases - Additional Information (Details) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022USD ($)option_to_renew | Dec. 31, 2021USD ($) | |
Lessee, Lease, Description [Line Items] | ||
Operating lease, right-of-use asset | $ 9,757 | $ 9,776 |
Operating lease liability | $ 10,397 | |
Lessee, Operating Leases, Number Of Renewal Options | option_to_renew | 1 | |
Buildings | ||
Lessee, Lease, Description [Line Items] | ||
Operating lease, right-of-use asset | $ 400 | |
Operating lease liability | $ 400 | |
Minimum | ||
Lessee, Lease, Description [Line Items] | ||
Renewal term | 1 year | |
Maximum | ||
Lessee, Lease, Description [Line Items] | ||
Renewal term | 5 years |
Leases - Balance Sheet Informat
Leases - Balance Sheet Information (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Right-of-Use-Assets | ||
Operating leases | $ 9,757 | $ 9,776 |
Liabilities | ||
Operating lease, liability, current | $ 1,736 | |
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] | Other accrued liabilities | |
Operating lease, liability, non-current | $ 8,661 | |
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] | Other liabilities | |
Total lease liabilities | $ 10,397 |
Leases - Lease Cost (Details)
Leases - Lease Cost (Details) $ in Thousands | 3 Months Ended |
Mar. 31, 2022USD ($) | |
Leases [Abstract] | |
Cost of sales, selling expenses and general and administrative expense | $ 669 |
Leases - Schedule of Lease Liab
Leases - Schedule of Lease Liabilities Maturity (Details) $ in Thousands | Mar. 31, 2022USD ($) |
Leases [Abstract] | |
2021 (remainder) | $ 1,846 |
2023 | 1,931 |
2024 | 1,840 |
2025 | 1,702 |
2026 | 1,472 |
Thereafter | 4,225 |
Total lease payments | 13,016 |
Less: interest | 2,619 |
Present value of lease payments | $ 10,397 |
Leases - Weighted-Average Lease
Leases - Weighted-Average Lease Information (Details) | Mar. 31, 2022 |
Leases [Abstract] | |
Weighted average remaining lease term (years) | 6 years 9 months 18 days |
Weighted average discount rate | 6.50% |
Leases - Cash Outflow Informati
Leases - Cash Outflow Information (Details) $ in Thousands | 3 Months Ended |
Mar. 31, 2022USD ($) | |
Leases [Abstract] | |
Operating cash outflows from operating leases | $ 713 |
Retirement Plans (Details)
Retirement Plans (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Defined Benefit Plan Disclosure [Line Items] | ||
Employer contribution amount | $ 0.1 | $ 0.1 |
Defined contribution plan, initial contribution | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Employer matching contribution, percent | 100.00% | |
Employer matching contribution, percent of employees gross pay | 3.00% | |
Defined contribution plan, additional contribution | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Employer matching contribution, percent | 50.00% | |
Employer matching contribution, percent of employees gross pay | 2.00% |
Related Party Transactions (Det
Related Party Transactions (Details) - USD ($) $ in Thousands | Mar. 18, 2013 | Mar. 31, 2022 | Mar. 31, 2021 |
Affiliated Entity | Management Agreement | |||
Related Party Transaction [Line Items] | |||
Annual management fees | $ 300 | ||
Expenses from agreement | $ 56 | ||
Management agreement, term | 5 years | ||
Additional renewal period term | 1 year | ||
Equity ownership needed to terminate agreement | 50.00% | ||
Engauge Workforce Solutions LLC ("Engauge") | |||
Related Party Transaction [Line Items] | |||
Expenses from agreement | $ 350 | ||
Agreement term | 12 months | ||
Written notice term | 60 days |
Earnings Per Share - Numerator
Earnings Per Share - Numerator and Denominator of Basic and Diluted Loss per Share Reconciliation (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Numerator: | ||
Net income (loss) | $ (569) | $ (1,069) |
Denominator: | ||
Weighted average shares outstanding, basic (in shares) | 11,733,147 | 9,779,147 |
Dilutive effect of stock-based awards (in shares) | 0 | 0 |
Weighted average shares outstanding, diluted (in shares) | 11,733,147 | 9,779,147 |
Earnings Per Share, Basic and Diluted [Abstract] | ||
Basic loss per share (in dollars per share) | $ (0.05) | $ (0.11) |
Diluted loss per share (in dollars per share) | $ (0.05) | $ (0.11) |
Earnings Per Share - Anti-Dilut
Earnings Per Share - Anti-Dilutive Common Stock Equivalents Summary (Details) - $ / shares | 1 Months Ended | 3 Months Ended | |
Sep. 30, 2021 | Mar. 31, 2022 | Mar. 31, 2021 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Number of options (in shares) | 833,084 | 726,500 | |
Exercise price of options lower limit (in dollars per share) | $ 2.08 | $ 2.36 | |
Exercise price of options upper limit (in dollars per share) | $ 12.50 | $ 12.58 | |
Warrants (in shares) | 156,320 | ||
Exercise price of warrants lower limit (in dollars per share) | $ 3.12 | ||
Warrants for Underwriters | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of EPS (in shares) | 156,320 |